SynthesisCancer medicine2023

Tyrosine kinase inhibitors in HER2-positive breast cancer brain metastases: A systematic review and meta-analysis.

Yushuai Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.